These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 32070043)

  • 1. Boron Chemistry for Medical Applications.
    Ali F; S Hosmane N; Zhu Y
    Molecules; 2020 Feb; 25(4):. PubMed ID: 32070043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accelerator-based boron neutron capture therapy for malignant glioma: a pilot neutron irradiation study using boron phenylalanine, sodium borocaptate and liposomal borocaptate with a heterotopic U87 glioblastoma model in SCID mice.
    Zavjalov E; Zaboronok A; Kanygin V; Kasatova A; Kichigin A; Mukhamadiyarov R; Razumov I; Sycheva T; Mathis BJ; Maezono SEB; Matsumura A; Taskaev S
    Int J Radiat Biol; 2020 Jul; 96(7):868-878. PubMed ID: 32339057
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of a novel sodium borocaptate-containing unnatural amino acid as a boron delivery agent for neutron capture therapy of the F98 rat glioma.
    Futamura G; Kawabata S; Nonoguchi N; Hiramatsu R; Toho T; Tanaka H; Masunaga SI; Hattori Y; Kirihata M; Ono K; Kuroiwa T; Miyatake SI
    Radiat Oncol; 2017 Jan; 12(1):26. PubMed ID: 28114947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine.
    Barth RF; Yang W; Rotaru JH; Moeschberger ML; Boesel CP; Soloway AH; Joel DD; Nawrocky MM; Ono K; Goodman JH
    Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):209-18. PubMed ID: 10758326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Theranostic Boron Neutron Capture Therapy Agents as Multimodal Radiopharmaceuticals.
    Jalilian AR; Shahi A; Swainson IP; Nakamura H; Venkatesh M; Osso JA
    Cancer Biother Radiopharm; 2022 Jun; 37(5):342-354. PubMed ID: 35426728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carborane-Containing Hydroxamate MMP Ligands for the Treatment of Tumors Using Boron Neutron Capture Therapy (BNCT): Efficacy without Tumor Cell Entry.
    Flieger S; Takagaki M; Kondo N; Lutz MR; Gupta Y; Ueda H; Sakurai Y; Moran G; Kempaiah P; Hosmane N; Suzuki M; Becker DP
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suitability of boron carriers for BNCT: accumulation of boron in malignant and normal liver cells after treatment with BPA, BSH and BA.
    Chou FI; Chung HP; Liu HM; Chi CW; Lui WY
    Appl Radiat Isot; 2009 Jul; 67(7-8 Suppl):S105-8. PubMed ID: 19375330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorinated borono-phenylalanine for optimizing BNCT: Enhancing boron absorption against hydrogen scattering for thermal neutrons.
    Romanelli G; Capuani S; Onorati D; Ulpiani P; Preziosi E; Andreani C; Senesi R
    Med Phys; 2024 Jan; 51(1):439-446. PubMed ID: 37956252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The basis and advances in clinical application of boron neutron capture therapy.
    He H; Li J; Jiang P; Tian S; Wang H; Fan R; Liu J; Yang Y; Liu Z; Wang J
    Radiat Oncol; 2021 Nov; 16(1):216. PubMed ID: 34743756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Boronated compounds for imaging guided BNCT applications.
    Geninatti-Crich S; Deagostino A; Toppino A; Alberti D; Venturello P; Aime S
    Anticancer Agents Med Chem; 2012 Jun; 12(5):543-53. PubMed ID: 22263798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A realistic appraisal of boron neutron capture therapy as a cancer treatment modality.
    Barth RF; Zhang Z; Liu T
    Cancer Commun (Lond); 2018 Jun; 38(1):36. PubMed ID: 29914575
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Boron delivery agents for neutron capture therapy of cancer.
    Barth RF; Mi P; Yang W
    Cancer Commun (Lond); 2018 Jun; 38(1):35. PubMed ID: 29914561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Rise of Boron-Containing Compounds: Advancements in Synthesis, Medicinal Chemistry, and Emerging Pharmacology.
    Grams RJ; Santos WL; Scorei IR; Abad-García A; Rosenblum CA; Bita A; Cerecetto H; Viñas C; Soriano-Ursúa MA
    Chem Rev; 2024 Mar; 124(5):2441-2511. PubMed ID: 38382032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Boron neutron capture therapy using dodecaborated albumin conjugates with maleimide is effective in a rat glioma model.
    Kashiwagi H; Kawabata S; Yoshimura K; Fukuo Y; Kanemitsu T; Takeuchi K; Hiramatsu R; Nishimura K; Kawai K; Takata T; Tanaka H; Watanabe T; Suzuki M; Miyatake SI; Nakamura H; Wanibuchi M
    Invest New Drugs; 2022 Apr; 40(2):255-264. PubMed ID: 34816337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A periodic development of BPA and BSH based derivatives in boron neutron capture therapy (BNCT).
    Lamba M; Goswami A; Bandyopadhyay A
    Chem Commun (Camb); 2021 Jan; 57(7):827-839. PubMed ID: 33399147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of drug delivery system to boron neutron capture therapy for cancer.
    Yanagië H; Ogata A; Sugiyama H; Eriguchi M; Takamoto S; Takahashi H
    Expert Opin Drug Deliv; 2008 Apr; 5(4):427-43. PubMed ID: 18426384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The acceleration of boron neutron capture therapy using multi-linked mercaptoundecahydrododecaborate (BSH) fused cell-penetrating peptide.
    Michiue H; Sakurai Y; Kondo N; Kitamatsu M; Bin F; Nakajima K; Hirota Y; Kawabata S; Nishiki T; Ohmori I; Tomizawa K; Miyatake S; Ono K; Matsui H
    Biomaterials; 2014 Mar; 35(10):3396-405. PubMed ID: 24452095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HER-2-Targeted Boron Neutron Capture Therapy with Carborane-integrated Immunoliposomes Prepared via an Exchanging Reaction.
    Kawasaki R; Oshige A; Yamana K; Hirano H; Nishimura K; Miura Y; Yorioka R; Sanada Y; Bando K; Tabata A; Yasuhara K; Miyazaki Y; Shinoda W; Nishimura T; Azuma H; Takata T; Sakurai Y; Tanaka H; Suzuki M; Nagasaki T; Ikeda A
    Chemistry; 2023 Dec; 29(72):e202302486. PubMed ID: 37792507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured boron agents for boron neutron capture therapy: a review of recent patents.
    Zhang X; Lin Y; Hosmane NS; Zhu Y
    Med Rev (2021); 2023 Oct; 3(5):425-443. PubMed ID: 38283251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of boron distribution in vivo for boron neutron capture therapy using two different boron compounds by secondary ion mass spectrometry.
    Yokoyama K; Miyatake S; Kajimoto Y; Kawabata S; Doi A; Yoshida T; Okabe M; Kirihata M; Ono K; Kuroiwa T
    Radiat Res; 2007 Jan; 167(1):102-9. PubMed ID: 17214510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.